08:00 , Dec 24, 2012 |  BC Week In Review  |  Company News

Lorus, Brock University deal

Lorus partnered with the university to develop cancer drugs based on chemical derivatives of pancratistatin, a natural compound. Lorus will be responsible for testing the anticancer activity and drug-like properties of pancratistatin derivatives synthesized by...